Favorable responses to treatment with 5 mg Sbv/kg/day meglumine antimoniate in patients with American tegumentary leishmaniasis acquired in different Brazilian regions

Favorable responses to treatment with 5 mg Sbv/kg/day meglumine antimoniate in patients with American tegumentary leishmaniasis acquired in different Brazilian regions

Abstract INTRODUCTION: Favorable responses in American tegumentary leishmaniasis (ATL) patients to treatment with 5 mg Sbv/kg/day meglumine antimoniate (MA) has been reported in Rio de Janeiro, but little is known regarding the therapeutic response to low doses in patients from other locations. ME...

Full description

Bibliographic Details
Main Authors: Jamyra Iglesias Cataldo, Fátima Conceição-Silva, Liliane de Fátima Antônio, Armando de Oliveira Schubach, Mauro Célio de Almeida Marzochi, Cláudia Maria Valete-Rosalino, Maria Inês Fernandes Pimentel, Marcelo Rosandiski Lyra, Raquel de Vasconcellos Carvalhaes de Oliveira, Juliana Helena da Silva Barros, Raquel da Silva Pacheco, Maria de Fátima Madeira
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT)
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
American tegumentary leishmaniasis
Leishmania spp.
Leishmania (Viannia) braziliensis subpopulations
Therapy
Meglumine antimoniate
Low-dose
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000600769&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000600769&lng=en&tlng=en

Similar Items